Русский
Nederlandse taal
Deutsch
Francés
한국어
Português
Español
日本語
ไทย
Sub Skin Cross Linked Hyaluronic Acid
Ingredient: 24mg/ml hyaluronic acid
Specification: 1ml, 2ml, 3ml, 5ml, 10ml, 20ml, 50ml
Package: Syringe
Recommended use: 1-3 pcs, 12 months apart
Application Area:Chest, buttocks and other filled and shaped body parts
Product Introduction：
Cross linked gel products are divided into single and double according to different processes and gel states, and according to different injection levels at the site of gel use, they are divided into five categories: sub-skin(D24+, S24+), deep (D24, S24), derm (D22, S22), fine(D20, HD20) and micro-crosslinked (D12).
In order to fill the lips, our company specially launched HD20 products, adding vitamins on the basis of D20 products, which can effectively avoid inflammation and promote cell regeneration.
Product Display：
Product Details:
Type | Sub skin |
Ingredient | Cross Linked Hyaluronic Acid Dermal Filler |
Specification | 1ml, 2ml, 3ml, 5ml, 10ml, 20ml, 50ml |
Cross Link | BDDE chemical cross link |
Texture | Gel |
Elasticity | 550 Pa-700 Pa |
Viscosity | 180 Pa-280 Pa |
Mean particle size | 450μm-650μm |
Effective content | 24mg/mL |
Cross linker residue | No,or≤0.5ug/g |
Protein residue | ≤20μg/g |
Endotoxin content | <0.5EU/mL |
Swelling degree | 20-35 |
Extruding force | 20N-30N |
Application area | Chest, buttocks and other filled and shaped body parts |
Package | Syringe |
Stoarge | Room temperature (1-25ºC), cool and dry place |
Recommended | 1-3 pcs (vary with each individual |
Recommended interval | 12 month |
Product Package:
Customer Feedback：
Raw Material Advantages：
1. Cross-linked hyaluronic acid demonstrates superior longevity compared to native HA, maintaining its structural integrity for extended periods through covalent bonding between polymer chains.
2. The enhanced viscoelastic properties of CLHA enable optimal tissue support and volume restoration in dermal filler applications.
Development Process:
Company Introduction:
Established in 2014, Jinan Grandwill Medical Technology stands at the forefront of biomedical innovation, specializing in R&D, production, and distribution of implantable medical devices and aesthetic materials. Our 5,000㎡ GMP-certified facilities house 4 ultra-clean Class 100 workshops and 6 automated production lines, supported by 11 granted patents (4 utility, 7 invention) and 6 pending innovations. Certified to ISO 13485 and FDA standards, we guarantee BDDE-free, heavy metal-safe products through rigorous sterilization protocols.
